Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

ID#: NCT04666077

Age: 55 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: July 25, 2019

End Date: January 31, 2024

Contact Information:
Allison Ardolino
212-585-4606
John Mondanaro, PhD, LCAT, MT-BC
212-420-2722
Summary:

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

Eligibility:



Inclusion Criteria:

- Diagnosis of Alzheimer's disease or mild cognitive impairment

- Must have study partner

- English speaking

- No verbal impairment

- Community-dwelling

- Must have webcam or smart phone

Exclusion Criteria:

- A diagnosis of dementia other than probable or possible AD

- Probable AD with Down syndrome

- History of a clinically significant stroke with residual deficit

- Current evidence or history in past two years of epilepsy, focal brain lesion, head injury

- Current diagnosis for major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse.

- Participation in another interventional study

- Comorbidity causing disability interfering with intervention such as pain or discomfort or life expectancy less than 1 year